Artiva Biotherapeutics, Inc. ARTV Operating Lease Liability Payments - 2026 (Lessee)
Operating Lease Liability Payments - 2026 (Lessee) at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s operating lease liability payments - 2026 (lessee).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s operating lease liability payments - 2026 (lessee)?
- Artiva Biotherapeutics, Inc. (ARTV) reported operating lease liability payments - 2026 (lessee) of $2.28M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s operating lease liability payments - 2026 (lessee) changed year-over-year?
- Artiva Biotherapeutics, Inc.'s operating lease liability payments - 2026 (lessee) decreased by 39.1% year-over-year, from $3.75M to $2.28M.
- What does operating lease liability payments - 2026 (lessee) mean?
- This represents the specific cash outflow commitment for operating leases scheduled for the calendar year 2026. It allows investors to isolate the impact of real estate and equipment lease obligations on the company's cash flow in a specific future period.